Literature DB >> 14588419

Subscale validity of the Mattis Dementia Rating Scale.

D C Marson1, M P Dymek, L W Duke, L E Harrell.   

Abstract

The Mattis Dementia Rating Scale (DRS), a widely used dementia screening instrument, generates five subscale scores in the areas of Attention (ATT), Initiation-Perseveration (IP), Construction (CN), Conceptualization (CON), and Memory (MEM). The present study sought to determine the criterion validity of the DRS subscales in a sample of 50 patients with Alzheimer's disease (25 with mild and 25 with moderate dementia). Subject performance on the five DRS subscales was correlated with performance on five well-validated neuropsychological criterion measures using Pearson r and stepwise regression. On a univariate level, each DRS subscale correlated most strongly with its assigned neuropsychological criterion measure. On a multivariate level, each DRS subscale emerged as the Step 1 predictor of its assigned criterion measure, with the exception of DRS CN, which was the Step 2 predictor. The results suggested that overall the DRS subscales are valid measures of their respective constructs and have value for both clinical and research purposes in mild and moderate dementia.

Entities:  

Year:  1997        PMID: 14588419

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  12 in total

1.  Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's disease.

Authors:  Kathy Dujardin; David Devos; Stéphane Duhem; Alain Destée; Rose-Marie Marié; Franck Durif; Lucette Lacomblez; Jacques Touchon; Pierre Pollak; Jean-Jacques Péré
Journal:  J Neurol       Date:  2006-09-22       Impact factor: 4.849

2.  Reliability and validity of the Executive Interview (EXIT) and Quick EXIT among community dwelling older adults.

Authors:  Grace B Campbell; Ellen M Whyte; Susan M Sereika; Mary Amanda Dew; Charles F Reynolds; Meryl A Butters
Journal:  Am J Geriatr Psychiatry       Date:  2013-10-08       Impact factor: 4.105

Review 3.  Lewy Body Disease: Clinical and Pathological "Overlap Syndrome" Between Synucleinopathies (Parkinson Disease) and Tauopathies (Alzheimer Disease).

Authors:  Clovis Foguem; Patrick Manckoundia
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-08       Impact factor: 5.081

Review 4.  A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples.

Authors:  Catherine E Prado; Stephanie Watt; Simon F Crowe
Journal:  Neuropsychol Rev       Date:  2018-02-14       Impact factor: 7.444

5.  Association of White Matter Integrity With Executive Function and Antidepressant Treatment Outcome in Patients With Late-Life Depression.

Authors:  Xiaofu He; Elena Pueraro; Yoojean Kim; Carolina Montes Garcia; Ben Maas; Jongwoo Choi; Dakota A Egglefield; Sophie Schiff; Joel R Sneed; Patrick J Brown; Adam M Brickman; Steven P Roose; Bret R Rutherford
Journal:  Am J Geriatr Psychiatry       Date:  2021-01-23       Impact factor: 4.105

6.  Cognitive control, reward-related decision making and outcomes of late-life depression treated with an antidepressant.

Authors:  G S Alexopoulos; K Manning; D Kanellopoulos; A McGovern; J K Seirup; S Banerjee; F Gunning
Journal:  Psychol Med       Date:  2015-07-14       Impact factor: 7.723

7.  Does Motor Symptoms Asymmetry Predict Motor Outcome of Subthalamic Deep Brain Stimulation in Parkinson's Disease Patients?

Authors:  Francesco Bove; Francesco Cavallieri; Anna Castrioto; Sara Meoni; Emmanuelle Schmitt; Amélie Bichon; Eugénie Lhommée; Pierre Pélissier; Andrea Kistner; Eric Chevrier; Eric Seigneuret; Stephan Chabardès; Franco Valzania; Valerie Fraix; Elena Moro
Journal:  Front Hum Neurosci       Date:  2022-06-21       Impact factor: 3.473

8.  What does the Dementia Rating Scale-2 measure? The relationship of neuropsychological measures to DRS-2 total and subscale scores in non-demented individuals with Parkinson's disease.

Authors:  Francesca V Lopez; Lauren E Kenney; Adrianna Ratajska; Charles E Jacobson; Dawn Bowers
Journal:  Clin Neuropsychol       Date:  2021-11-15       Impact factor: 4.373

9.  Cognitive discrepancies versus APOE genotype as predictors of cognitive decline in normal-functioning elderly individuals: a longitudinal study.

Authors:  Eric M Fine; Dean C Delis; Spencer R Wetter; Mark W Jacobson; Amy J Jak; Carrie R McDonald; Jodessa C Braga; Leon J Thal; David P Salmon; Mark W Bondi
Journal:  Am J Geriatr Psychiatry       Date:  2008-05       Impact factor: 4.105

10.  Antidepressant medication and executive dysfunction: a deleterious interaction in late-life depression.

Authors:  Joel R Sneed; Michelle E Culang; John G Keilp; Bret R Rutherford; Davangere P Devanand; Steven P Roose
Journal:  Am J Geriatr Psychiatry       Date:  2010-02       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.